The trial examines a medication that combines two antibiotics, Amoxicillin/Clavulanic acid, provided as a powder that is mixed with water to create a liquid oral suspension. The same antibiotic combination is also available as a branded product called Augmentin ES, which is prepared in the same way. The study enrolls adult men and women who are healthy and do not have an infection.

The purpose is to assess whether the test product and the branded product are bioequivalence, meaning they provide the same amount of medicine to the body. Participants will take one of the liquid preparations after a regular meal, then, after a short interval, will take the other preparation after another meal. Blood samples will be collected to compare how the two products are absorbed, without further technical detail.